tiprankstipranks
Faron’s Founders Finalists for European Inventor Award
Company Announcements

Faron’s Founders Finalists for European Inventor Award

Faron Pharmaceuticals Oy (GB:FARN) has released an update.

Faron Pharmaceuticals Oy’s co-founders, Dr. Markku Jalkanen and Dr. Sirpa Jalkanen, have been honored as finalists for the European Inventor Award 2024 in the ‘SMEs’ category, in recognition of their work on bexmarilimab, a promising cancer immunotherapy. Bexmarilimab, which is in clinical trials, aims to reprogram myeloid cells to fight tumors and improve outcomes for patients with few treatment options. The company is advancing in its mission to utilize immunotherapies to address challenging cancers.

For further insights into GB:FARN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskFaron Pharmaceuticals Gains FDA Nod for Bexmarilimab Study
TipRanks UK Auto-Generated NewsdeskFaron Pharmaceuticals Completes Major Share Offering
TipRanks UK Auto-Generated NewsdeskFaron Pharmaceuticals Corrects Shareholding Data
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!